American Diabetes Association Thanks the 2016 Principal Officers and Welcomes 2017 Officers to National Board of Directors


Michelle Kirkwood

Arlington, Virginia
January 4, 2017

The American Diabetes Association (Association), the nation's largest voluntary health organization leading the fight to Stop Diabetes®, thanks the four Principal Officers whose terms of leadership service ended in 2016 and welcomes the new 2017 Principal Officers and Board of Directors.

"It is with deep gratitude that we thank our 2016 Principal Officers, Robin Richardson, Drs. Desmond Schatz and Maggie Powers, and Lorrie Liang, for their exceptional service to the Association," said Kevin L. Hagan, Chief Executive Officer. "Their expertise and experience helped advance the Association's mission this year and helped position us for the year ahead." Hagan added, "We also welcome our 2017 Principal Officers, Drs. Dave DeMarco and Alvin Powers, Brenda Montgomery and Umesh Verma whose leadership will be critical in the implementation of the Association's new Strategic Plan. We're fortunate to have a deep team with exceptional skills and experience."

The Principal Officers of the Board whose terms of leadership service ended on December 31, 2016 are:

Robin Richardson, Portland, OR (2016 Chair of the Board)

Richardson is Senior Vice President of Moda Health, where he is the senior executive responsible for the company's Integrated Health Systems, Pharmacy, Legislative, Medicare, and Medicaid programs as well as its Human Resources and Facilities departments. As Chair, Richardson helped lead the Association through the development of a four-year strategic plan that will guide the Association into a new direction, while strengthening its long-standing core competencies.

Margaret (Maggie) Powers, PhD, RD, CDE, Minneapolis, MN (2016 President, Health Care & Education)

Powers conducts research and has a clinical practice as a registered dietitian and diabetes educator at the International Diabetes Center at Park Nicollet in Minneapolis. Her research focuses on improving diabetes outcomes including factors that affect the clinical, psychosocial and behavioral aspects of diabetes. As President, Health Care & Education, Dr. Powers helped the Association elevate the discourse and awareness around the effectiveness and critical need for more physicians and patients with diabetes to have access and utilize diabetes self-management education tools.

Desmond Schatz, MD, Gainesville, FL (2016 President, Science & Medicine)

Schatz is the Medical Director of the Diabetes Center, Professor and Associate Chairman of Pediatrics and Director of the Clinic Research Center at the University of Florida. As President, Science & Medicine, Dr. Schatz helped raise renewed urgency around the diabetes epidemic and brought needed attention to the human and financial cost of the disease.

Lorrie Welker Liang, Sarasota, FL (2016 Secretary/Treasurer)

Liang is Chief Operating Officer of Sarasota Memorial Health Care System. Prior to this appointment she served as Vice President of Sinai Hospital of Baltimore, a member of the Lifebridge Health System. Liang is a ten-plus year Volunteer and has been the Chair of her local Community Leadership Board.

The 2017 Principal Officers of the Board of Directors who began their terms of service on January 1, 2017 are:

David A. DeMarco, PhD, Wakefield, RI (2017 Chair of the Board)

David DeMarco is Partner and U.S. Health Deputy Leader for Ernst & Young LLP and serves as the Northeast Region Life Sciences Market Segment leader, where he oversees the full range of audit, tax, transaction and advisory services for the Firm's pharmaceutical, biotech and medtech practice within the region. Dr. DeMarco has been volunteering for the American Diabetes Association since July 2011 and served as Chair of the Association's Metro New York City Community Leadership Board.

Brenda Montgomery, RN, MSHS, CDE, Bellevue, WA (2017 President, Health Care & Education)¹

Brenda Montgomery is a Clinical Science Liaison for AstraZeneca Pharmaceuticals where she works with primary care providers to help with the treatment of diabetes and to ensure that they are up-to-date on standards of care, research and science. Montgomery has served as President of her area's American Diabetes Association Community Leadership Board and chaired the Association's EXPO for two years.

Alvin C. Powers, MD, Nashville, TN (2017 President, Medicine & Science)

Alvin Powers is the Joe C. Davis Chair in Biologic Science and Professor of Medicine, Molecular Physiology and Biophysics at Vanderbilt University in Nashville, Tenn. He is also the Director of the Vanderbilt Diabetes Center, Chief of the Vanderbilt Division of Diabetes, Endocrinology and Metabolism, and the Director of the Vanderbilt Diabetes Research and Training Center, a NIH-funded center that facilitates the diabetes-related research of more than 120 Vanderbilt scientists. Dr. Powers has served on the Association's Finance, Scientific Sessions Planning, and Research Policy Committees.

Umesh Verma, Houston, TX (Secretary/Treasurer)

Umesh Verma is Chief Executive Officer of BLUE LANCE, Inc., a global provider of cybersecurity governance solutions that help companies save time and money with information security risk assessments, auditing and compliance automation. Verma has served as Chair of the American Diabetes Association's Houston Community Leadership Board and on the Association's Finance Committee.

The Elect Officers for 2018 are:

Jeffrey Himmel, MS, Miami Beach, FL (Chair-Elect of the Board)²

Jeffrey Himmel is Chairman and Chief Executive Officer of The Himmel Group, Himmel Pharmaceuticals and Himmel Media which markets consumer health care brands, over-the-counter (OTC) pharmaceuticals and health and nutrition products. Himmel has served as the Chair of the Association’s Strategic Planning Oversight Group and has been involved with the Association’s New York City Step Out event.

Felicia Hill-Briggs, PhD, ABPP, Baltimore, MD (President-Elect, Health Care & Education)

Felicia Hill-Briggs is Professor of Medicine, Division of General Internal Medicine, Director, Behavior and Cognition Sub-Core, Healthcare & Population Science, Baltimore Diabetes Research Center, and Senior Director, Population Health Research and Development at The Johns Hopkins University School of Medicine, Welch Center for Prevention, Epidemiology, and Clinical Research. Dr. Hill-Briggs has chaired the American Diabetes Association's Council on Behavioral Medicine and Psychology and served on the Grant Review Committee. She currently serves on the Association's Research Policy Committee.

Jane Reusch, MD, Denver, CO (President-Elect, Medicine & Science)

Jane Reusch is a Professor of Medicine at the University of Colorado at Denver and Health Sciences Center. She is also the Director of the Diabetes Care Team at the Denver VA Medical Center. She is a diabetes researcher with both clinical and basic research science programs. Dr. Reusch serves on the Association's Research Policy and Finance Committees and has served on the 2012 Scientific Sessions Meeting Planning Committee.

Michael Ching, CPA, Honolulu, HI (Secretary/Treasurer-Elect)

Michael Ching is an Executive Vice President of First Hawaiian Bank and serves as the Chief Financial Officer and Treasurer, overseeing all finance, accounting, and treasury functions of the bank. First Hawaiian Bank is the largest bank headquartered in Hawaii in terms of assets, loans, deposits and net income. Ching also currently serves as a member of the American Diabetes Association's Finance Committee as well as the Association's Honolulu Community Leadership Board. Ching previously served on the Association's Board of Directors from 2012-2014.

At-Large Board Members are:

Jackie Boucher, MS, RD, LD, CDE, Minneapolis, MN

Jackie Boucher is President of Children's HeartLink in Minneapolis, MN. In this position she leads an organization focused on training doctors and nurses in underserved parts of the world to diagnose and treat children with heart disease, ensuring they receive quality care. Boucher served on the Association's Postgraduate Course and Scientific Sessions Planning Committee as well as a three-year term as Associate Editor and five-year term as Editor-in-Chief of Diabetes Spectrum.

Janet Brown Friday, RN, MSN, MPH, Bronx, NY

Janet Brown Friday has been a registered nurse for 34 years and is currently the Clinical Trials Manager at the Albert Einstein College of Medicine, overseeing the operation of both National Institutes of Health-funded and local clinical trials in the Diabetes Clinical Trials Unit. Friday has served on the Association's African American Committee.

Martha Clark, MBA, Lafayette, CA

Martha Clark is a retired senior-level executive with experience spanning the strategy consulting, asset management and banking industries. Clark has served as Chair of the Association's Community Leadership Board for the San Francisco Bay Area and is also Chair of the Association's Finance Committee.

Robert H. Eckel, MD, Aurora, CO

Robert Eckel is a Distinguished Alumnus of the University of Cincinnati College of Medicine and currently the Charles A. Boettcher II Endowed Chair in Atherosclerosis, Professor of Medicine with appointments in the Division of Endocrinology, Metabolism and Diabetes and the Division of Cardiology, and Professor of Physiology and Biophysics at the University of Colorado School of Medicine Anschutz Medical Campus, and Director of the Lipid Clinic at the University of Colorado Hospital. Dr. Eckel served on the Association's Mentor Advisory Group.

David Herrick, New York, NY

David Herrick is Principal, Hudson Cutler & Co. in New York City, where he leads an integrated marketing communications firm that provides counsel to corporate and non-profit clients on strategies for building the relevance of their brands. Herrick has served on the Association's Greater New York City Community Leadership Board as Chair and has been heavily involved as an organizer and participant in the Association's Tour de Cure events.

C. Ronald Kahn, MD, Newton, MA

C. Ronald Kahn is Mary K. Iacocca Professor of Medicine, Harvard Medical School; Chief Academic Officer, Senior Investigator and Head of the Section on Integrative Physiology and Metabolism at Joslin Diabetes Center in Boston, Massachusetts. He's held memberships on a number of the Association's national committees, including the Research Policy and Finance Committees. Dr. Kahn also served as the Associate Review Editor of Diabetes Care from 1990-1992.

Steve Lucas, Denver, CO

Steve Lucas is Chief Executive Officer at Marketo, Inc., a leader in marketing automation located in Denver, CO. Prior to Marketo, Lucas served as President of SAP's Platform Solutions, leading the organization's multibillion-dollar growth and expansion into a range of technology markets. Mr. Lucas has held leadership positions at other large technology companies, including Microsoft,, Crystal Decisions, and Business Objects. Lucas served as the executive champion for SAP’s involvement as a Tour de Cure National Team while at SAP. Lucas also served as an advisor for the development of the Association's 2016 Technology Summit and was a presenter at the event.

Calvin Schmidt, BE, MBA, Raritan, NJ

Calvin Schmidt is President, Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson. In this role, he leads a business that is making a significant difference for patients suffering from cardiovascular and metabolic diseases. Schmidt serves on the Association's Audit Committee and has supported the Association's health disparities initiatives, with specific focus on reducing the impact of diabetes in minority communities.

Catherine Squires, CFRE, DeKalb, IL

Catherine Squires is President and CEO, Northern Illinois University Foundation and Vice President for University Advancement at Northern Illinois University, where she is responsible for leading all advancement and alumni activities as well as managing the endowment of one of Illinois' largest universities. Squires has extensive professional fundraising and volunteer experience and serves on the Association's Finance Committee.

Alan L. Yatvin, JD, Philadelphia, PA

Alan Yatvin is Managing Partner of the Philadelphia firm, Popper & Yatvin, where he concentrates his practice on police misconduct civil rights litigation, criminal defense in state and federal court and representation of students with special needs, focusing on the rights and needs of those living with diabetes. Yatvin has served as Chair of the American Diabetes Association's Legal Advocacy Subcommittee and serves on the Finance Committee.

About the American Diabetes Association

Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)

1. Disclosures for Brenda Montgomery. Employer: AstraZeneca Pharmaceuticals. Montgomery’s role as President, Health Care & Education of the American Diabetes Association (Association) is a voluntary position to which she was elected by the members of the Association in 2015. She continues to recuse herself from any and all discussions, decisions or votes that have or could be perceived as having a conflict of interest with her employer.
2. Jeffrey Himmel resigned from the Board of Directors on April 6, 2017.